Since 2018, Ozempic has been linked to nearly 9,000 cases of gastrointestinal side effects, including vomiting, nausea, and abdominal pain.
The FDA recently added a new potential adverse reaction to the label of type 2 diabetes drug Ozempic.
Though it’s still too early to say that Ozempic is definitively causing ileus, reports of this side effect join the more than 14,000 other cases of Ozempic side effects reported since 2018—nearly 9,000 of which have been linked to various gastrointestinal issues, like, vomiting, diarrhea, upper abdominal pain, and abdominal dissension.
“[It] doesn’t mean the drug shouldn’t be used. It has many benefits,” Hatipoglu told“Being fearful [of] using the drug because of this rare side effect is not fair for patients who will benefit from it.” Again, without more concrete information regarding the specific ileus cases the FDA is referencing, it’s challenging to say if or how Ozempic in particular is leading to these kinds ofHowever, Hatipoglu said, the way that the medication works could leave vulnerable people to these kinds of blockages.Ozempic works
“The most important side effects that we warn our patients at the beginning is this nausea, vomiting, constipation, or rarely, diarrhea,” she said. “They’re all linked to the same concept—[Ozempic] affects the movement of the bowels and the stomach. The benefits come somehow from the same pathway.”
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why Clint Eastwood's American Sniper Uses A Fake Baby (& Why It Looks So Terrible)The American Sniper prop baby was plan C.
Read more »
Why the new COVID shot is a game-changer (and why the term ‘booster’ is obsolete)The latest vaccine formula is available in local pharmacies now. Experts say it will be like the annual flu shot: one and done. Here’s why.
Read more »
Eli Lilly gets FDA complete response letter for skin treatment after inspection of third-party facilityEli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for...
Read more »
Eli Lilly Gets FDA Letter About Eczema Drug ConcernsThe pharmaceutical company says the letter cited no worries about the safety of its lebrikizumab skin treatment.
Read more »